Continuous Administration of Subcutaneous Levodopa/Carbidopa (ND0612) Demonstrated Comparable Levodopa Pharmacokinetics to Levodopa/Carbidopa Intestinal Gel (LCIG)

被引：0
|
作者：
Adar, Liat [1 ]
Minei, Tamar Rachmilewitz [1 ]
Cohen, Yael [1 ]
Oren, Sheila [1 ]
机构：
[1] NeuroDerm Ltd, Rehovot, Israel
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S4.003
引用
收藏
页数：2
相关论文
共 50 条
  • [31] POPULATION PHARMACOKINETICS OF LEVODOPA AND CARBIDOPA FOLLOWING SUBCUTANEOUS INFUSION
    Birnberg, T.
    Adar, L.
    Smania, G.
    Bjornsson, M.
    Jonsson, N.
    Case, R.
    Karlsson, M. O.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 47 - 47
  • [32] Ninety-day Local Tolerability and Toxicity Study of ND0612, a Novel Formulation of Levodopa/Carbidopa, Administered by Subcutaneous Continuous Infusion in Minipigs
    Ramot, Yuval
    Nyska, Abraham
    Maronpot, Robert R.
    Shaltiel-Karyo, Ronit
    Tsarfati, Yonit
    Manno, Rosa Anna
    Sacco, Giuseppe
    Yacoby-Zeevi, Oron
    TOXICOLOGIC PATHOLOGY, 2017, 45 (06) : 764 - 773
  • [33] LONG-TERM SAFETY OF CONTINUOUS LEVODOPA/CARBIDOPA INFUSION WITH ND0612: RESULTS FROM THE ONGOING BEYOND STUDY
    Poewe, W.
    Stocchi, F.
    Sopromadze, S.
    Adar, L.
    Sasson, N.
    Yardeni, T.
    Giladi, N.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 46 - 46
  • [34] Long-term safety of continuous levodopa/carbidopa infusion with ND0612: Results from the ongoing BeyoND study
    Poewe, W.
    Stocchi, F.
    Sopromadze, S.
    Adar, L.
    Sasson, N.
    Yardeni, T.
    Giladi, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 181 - 181
  • [35] Levodopa Pharmacokinetics in Switching From Levodopa/Carbidopa Intestinal Gel to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson's Disease: A Case Report
    Nukariya, Tomonori
    Tezuka, Toshiki
    Okusa, Shohei
    Okochi, Ryotaro
    Sakai, Yuto
    Nihei, Yoshihiro
    Nakahara, Jin
    Seki, Morinobu
    JOURNAL OF MOVEMENT DISORDERS, 2025,
  • [36] Frequent administration of levodopa/carbidopa microtablets vs levodopa/carbidopa/entacapone in healthy volunteers
    Nyholm, D.
    Ehrnebo, M.
    Lewander, T.
    Trolin, C. G.
    Backstrom, T.
    Panagiotidis, G.
    Spira, J.
    Nystrom, C.
    Aquilonius, S. -M.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 127 (02): : 124 - 132
  • [37] Continuous Subcutaneous Levodopa/Carbidopa Infusion with ND0612 For Parkinson's Disease: Three-year Data from the Openlabel BeyoND Study
    Poewe, W.
    Ellenbogen, A.
    Stocchi, F.
    Adar, L.
    Salin, L.
    Case, R.
    Yardeni, T.
    Giladi, N.
    MOVEMENT DISORDERS, 2023, 38 : S46 - S46
  • [38] The effect of tolcapone on levodopa pharmacokinetics is independent of levodopa/carbidopa formulation
    K. Jorga
    Barbel Fotteler
    Greg Sedek
    Thorkild Nielsen
    John Aitken
    Journal of Neurology, 1998, 245 : 223 - 230
  • [39] Loss of Weight Associated with Levodopa / Carbidopa Intestinal Gel
    Contreras, A.
    Carrascal, M.
    Breton, I.
    Grandas, F.
    MOVEMENT DISORDERS, 2020, 35 : S317 - S317
  • [40] The Prephase Nursing in Levodopa Carbidopa Intestinal Gel Therapy
    Lezzi, Pierluigi
    Lupo, Roberto
    Lezzi, Tania
    Vitale, Elsa
    JOURNAL OF NEUROSCIENCE NURSING, 2022, 54 (05) : 215 - 219
12345